KRAS and neoplasm: Furthermore, although EGFR and K-ras mutations are in general mutually exclusive in NSCLC patients [37], a K-Ras mutation (G12V) was detected in tumor cells bearing the P848L allele (Gallegos-Ruiz et al., unpublished).